SCRS Summits and COVID-19 Plan
The Summits provide a unique venue where sites, sponsors, CRO executives and regulators join together and share trends and best practices, communicate and collaborate about the latest knowledge, and develop new partnerships through sessions, workshops, focus groups and networking opportunities.
The COVID-19 pandemic continues to make an impact on the clinical research industry, and on each of us personally and professionally. As national and global efforts to contain the virus are underway, the impact on attendees, speakers and exhibiting organizations continues.
SCRS will continuously monitor the situation globally as the safety of Summit attendees and our commitment to offering an engaging and educational conference is of paramount importance.
Visit each respective SCRS Summit website for the latest information on agendas, travel guidances, and safety precautions. Reach out to firstname.lastname@example.org with any questions.
SCRS Advocates for Sites
COVID-19 Vaccine Distribution Access for Clinical Research Professionals – ASTHO
December 22, 2020
COVID-19 Vaccine Distribution Access for Clinical Research Professionals – NGA
December 22, 2020
SCRS Calls on Sponsors to Release Holdback Funds in Response to COVID-19
April 2, 2020
The Importance of Decentralized Clinical Trials
For the patients we pledge to serve, there is #NoGoingBack
As an industry, we learned bold new ways to conduct trials due to COVID-19. Now that we have seen the future so clearly, there is no going back. Whether you work at a sponsor, site, provider, advocacy group or other healthcare organization, please join in the mission to keep trials moving forward. Make the pledge today and have your name posted in support of #NoGoingBack.
‘No going back’ for clinical trials after COVID
Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result. The next step is ensuring the industry does not regress to old ways of working once the pandemic is over, say Karen McIntyre and Allyson Small.
COVID-19 Partnership Resource Exchange
Many of SCRS’ partners have taken action to support the site community as you navigate the COVID-19 pandemic. SCRS has created the COVID-19 Partnership Resource Exchange so that you have access to these resources in one easy-to-navigate place. Many organizations have created their own COVID-19 resource pages – we encourage you to check out what each company is doing to support the clinical research industry. Check back regularly for updates from new partners.
SCRS Virtual Summit Series
COVID-19 has had a tremendous impact on the clinical research industry. Conferences have been cancelled, travel restrictions are increasing and additional barriers are being experienced by sites, sponsors, CROs and patients alike.
SCRS recognizes the need for continuing education opportunities in light of the extensive clinical research conference cancellations due to COVID-19. In response, we have created an
8-part, complimentary Virtual Summit Series which will provide the opportunity to obtain needed education and gain a deeper understanding of how this globally adverse situation is affecting sites.
Topics covered included site preparedness for COVID-19, business development, decentralized clinical trials (DCTs), disaster planning, becoming the site of choice and more.
Sponsored by VirTrial
Questions and Answers from 03/24/2020 Site Panel – COVID-19 Preparedness – What is Happening Now
Questions and Answers from 3/31/2020 Webinar – Business Continuity: GCP Compliant Clinical Trials
Questions and Answers from 4/9/2020 Webinar – Relationship Building and How to Get More Business
Questions and Answers from 4/16/2020 Webinar – COVID-19 Site Impact Panel, Part 2: A Reflection and Best Practices for the Future
Questions and Answers from 4/21/2020 Webinar – A Good Site is Not Hard to Find
Unintended Impact of COVID-19 on Cancer
The Unintended Impact of COVID-19 on Cancer
June 18, 2020
Over the last few months, many patients have been in fear of their cancer journey. This fear had nothing to do with receiving their diagnosis or walking into a screening because of a found lump or increased risk. It wasn’t about dealing with the side effects of their chemotherapy, surgery, or radiation treatment. And, it was not caused by the stress felt when waiting for results from a significant medical test or scan. The fear was caused by our country’s myopic focus on flatting the COVID-19 curve. While we may have successfully flattened the proverbial curve, we have created a potentially larger, more dangerous shadow curve in the world of cancer.
SCRS COVID-19 Site Preparedness Survey Results
The emergence of the novel Coronavirus/COVID-19 has been a true test of the Society for Clinical Research Sites’ (SCRS’) mission: to unify the voice of the global clinical research site community for greater site sustainability. On March 12th, SCRS released a survey to better understand the challenges sites are facing, their level of preparation to navigate the current global reality and site needs related to the COVID-19 pandemic. It is important that SCRS continue to be the leader in advocating for site needs and educating the clinical research industry regarding how to navigate and address the challenges our industry is facing.